The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands
Open accessAbstract
Background: Mucolipidoses II and III alpha/beta (ML II and ML III) are lysosomal disorders in which the essential mannose 6-phosphate recognition marker is not synthesised on to lysosomal hydrolases and other glycoproteins. The disorders are caused by mutations in GNPTAB, which encodes two of three subunits of the heterohexameric enzyme, N-acetylglucosamine-1-phosphotransferase. Objectives: Clinical, biochemical and molecular findings in 61 probands (63 patients) are presented to provide a broad perspective of these mucolipidoses. Methods: GNPTAB was sequenced in all probands and/or parents. The activity of several lysosomal enzymes was measured in plasma, and GlcNAc-1-phosphotransferase was assayed in leucocytes. Thirty-six patients were studied in detail, allowing extensive clinical data to be abstracted. Results: ML II correlates with near-total absence of phosphotransferase activity resulting from homozygosity or compound heterozygosity for frameshift or nonsense mutations. Craniofacial and orthopaedic manifestations are evident at birth, skeletal findings become more obvious within the first year, and growth is severely impaired. Speech, ambulation and cognitive function are impaired. ML III retains a low level of phosphotransferase activity because of at least one missense or splice site mutation. The phenotype is milder, with minimal delays in milestones, the appearance of facial coarsening by early school age, and slowing of growth after the age of 4 years. Conclusions: Fifty-one pathogenic changes in GNPTAB are presented, including 42 novel mutations. Ample clinical information improves criteria for delineation of ML II and ML III. Phenotype–genotype correlations suggested in more general terms in earlier reports on smaller groups of patients are specified and extended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reitman, M. L., Varki, A., & Kornfeld, S. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110189 · Cited by 321
Hasilik, A., Waheed, A., & von Figura, K. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91177-3 · Cited by 295
I-Cell Disease: Biochemical Studies
Leroy, J. G., Ho, M. W., Macbrinn, M. C., Zielke, K., Jacob, J., & O'brien, J. S. (1972) · Pediatric Research · doi:10.1203/00006450-197210000-00002 · Cited by 211
Self-citation
Cited by
Lysosomal enzyme trafficking: from molecular mechanisms to human diseases
Braulke, T., Carette, J. E., & Palm, W. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.06.005 · Cited by 76
Mannose 6-phosphate receptor homology (MRH) domain-containing lectins in the secretory pathway
Castonguay, A. C., Olson, L. J., & Dahms, N. M. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.016 · Cited by 36
“However, impaired GlcNAcphosphotransferase activity results in the mis-sorting and secretion of numerous lysosomal enzymes due to their inability to acquire Man-6-P residues and be trafficked by the MPRs, causing the LSDs, mucolipidosis II and III (also referred to as “I-cell disease” and “pseudoHurler polydystrophy”,…”
Background
Metadata
- Authors
- Cathey, S. S., Leroy, J. G., Wood, T., Eaves, K., Simensen, R. J., Kudo, M., Stevenson, R. E., & Friez, M. J.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2009-07-16
- Volume
- 47
- Issue
- 1
- Pages
- 38-48
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2122947761
- Cited by
- 158
- References
- 3
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. https://app.cochat.ai/papers/10.1136/jmg.2009.067736
- The paper
- Cathey, S. S., Leroy, J. G., Wood, T., Eaves, K., Simensen, R. J., Kudo, M., Stevenson, R. E., & Friez, M. J. (2010). Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. Journal of Medical Genetics. https://doi.org/10.1136/jmg.2009.067736
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.